BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17698751)

  • 1. High-frequency ultrasound characteristics of 24 iris and iridociliary melanomas: before and after plaque brachytherapy.
    Finger PT; Reddy S; Chin K
    Arch Ophthalmol; 2007 Aug; 125(8):1051-8. PubMed ID: 17698751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound biomicroscopy features of iris and ciliary body melanomas before and after brachytherapy.
    Torres VL; Allemann N; Erwenne CM
    Ophthalmic Surg Lasers Imaging; 2005; 36(2):129-38. PubMed ID: 15792314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
    Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
    Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
    Finger PT
    Am J Ophthalmol; 2001 Sep; 132(3):328-35. PubMed ID: 11530044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression Patterns of Iris Melanoma after Palladium-103 (
    Chaugule SS; Finger PT
    Ophthalmology; 2017 Jul; 124(7):1023-1030. PubMed ID: 28377036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of radiation maculopathy after palladium-103 plaque radiotherapy for iris melanoma.
    Yousef YA; Finger PT
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1107-12. PubMed ID: 22172910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy.
    Pe'er J; Averbukh E; Frenkel S
    Clin Exp Ophthalmol; 2009 Sep; 37(7):742-3. PubMed ID: 19788674
    [No Abstract]   [Full Text] [Related]  

  • 8. Ruthenium plaque radiation for iris and iridociliary melanomas: development of dry eyes?
    Razzaq L; de Keizer RJ
    Br J Ophthalmol; 2010 Nov; 94(11):1549-50. PubMed ID: 20516146
    [No Abstract]   [Full Text] [Related]  

  • 9. Ultrasound biomicroscopy in the diagnosis and management of anterior segment tumors.
    Reminick LR; Finger PT; Ritch R; Weiss S; Ishikawa H
    J Am Optom Assoc; 1998 Sep; 69(9):575-82. PubMed ID: 9785732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iris and ciliary body melanomas: ultrasound biomicroscopy with histopathologic correlation.
    Marigo FA; Finger PT; McCormick SA; Iezzi R; Esaki K; Ishikawa H; Liebmann JM; Ritch R
    Arch Ophthalmol; 2000 Nov; 118(11):1515-21. PubMed ID: 11074808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plaque radiotherapy for anterior uveal melanomas].
    Saakyan SV; Amiryan AG; Valskiy VV; Mironova IS
    Vestn Oftalmol; 2015; 131(2):5-12. PubMed ID: 26080576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruthenium-106 brachytherapy for iris and iridociliary melanomas.
    Marinkovic M; Horeweg N; Laman MS; Bleeker JC; Ketelaars M; Peters FP; Luyten GPM; Creutzberg CL
    Br J Ophthalmol; 2018 Aug; 102(8):1154-1159. PubMed ID: 29122824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior plaque brachytherapy placement for treatment of iris and iridociliary melanomas - Surgical procedure and institutional experience.
    Pike S; Engelhard SB; Greig LC; Woods K; Jennelle RL; Berry JL
    Indian J Ophthalmol; 2024 Jun; 72(6):912-915. PubMed ID: 38189366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small ciliary body tumors: ultrasound biomicroscopic assessment and follow-up of 42 patients.
    Weisbrod DJ; Pavlin CJ; Emara K; Mandell MA; McWhae J; Simpson ER
    Am J Ophthalmol; 2006 Apr; 141(4):622-8. PubMed ID: 16564795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of iris melanomas with 125Iodine plaque radiotherapy.
    Fernandes BF; Krema H; Fulda E; Pavlin CJ; Payne DG; McGowan HD; Simpson ER
    Am J Ophthalmol; 2010 Jan; 149(1):70-6. PubMed ID: 19892312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical decision aids using ultrasound biomicroscopy].
    Bergmann U; Guthoff R
    Klin Monbl Augenheilkd; 1994 Dec; 205(6):361-3. PubMed ID: 7869687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy.
    Demirci H; Saponara F; Khan A; Niziol LM; Lee C; Hayman JA; Comer G; Musch DC
    Middle East Afr J Ophthalmol; 2015; 22(1):103-7. PubMed ID: 25624683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical Coherence Tomography Angiography Characteristics of Iris Melanocytic Tumors.
    Skalet AH; Li Y; Lu CD; Jia Y; Lee B; Husvogt L; Maier A; Fujimoto JG; Thomas CR; Huang D
    Ophthalmology; 2017 Feb; 124(2):197-204. PubMed ID: 27856029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
    Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in ultrasound findings in posterior uveal melanoma after Ruthenium 106 brachytherapy.
    Kaiserman I; Anteby I; Chowers I; Blumenthal EZ; Kliers I; Pe'er J
    Ophthalmology; 2002 Jun; 109(6):1137-41. PubMed ID: 12045056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.